Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+30.28%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$116B
AUM Growth
+$12.9B
Cap. Flow
-$7.32B
Cap. Flow %
-6.32%
Top 10 Hldgs %
14.35%
Holding
3,987
New
586
Increased
1,423
Reduced
1,366
Closed
597

Top Buys

1
ZM icon
Zoom
ZM
+$1.14B
2
ABBV icon
AbbVie
ABBV
+$537M
3
TMUS icon
T-Mobile US
TMUS
+$504M
4
BIDU icon
Baidu
BIDU
+$474M
5
KR icon
Kroger
KR
+$448M

Sector Composition

1 Healthcare 23.45%
2 Technology 16.11%
3 Consumer Staples 10.59%
4 Consumer Discretionary 9.95%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
IMVT icon
2601
Immunovant
IMVT
$2.82B
$884K ﹤0.01%
+36,300
New +$884K
SOL
2602
Emeren Group
SOL
$96.5M
$884K ﹤0.01%
776,486
+32,135
+4% +$36.6K
HLIT icon
2603
Harmonic Inc
HLIT
$1.13B
$882K ﹤0.01%
185,599
+111,400
+150% +$529K
HHS icon
2604
Harte-Hanks
HHS
$28.3M
$881K ﹤0.01%
289,944
+29,603
+11% +$89.9K
TARA icon
2605
Protara Therapeutics
TARA
$121M
$879K ﹤0.01%
29,986
+4,100
+16% +$120K
ALR
2606
DELISTED
AlerisLife Inc. Common Stock
ALR
$879K ﹤0.01%
225,373
+7,000
+3% +$27.3K
ICBK
2607
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$877K ﹤0.01%
41,895
+2,800
+7% +$58.6K
LJPC
2608
DELISTED
La Jolla Pharmaceutical Company
LJPC
$876K ﹤0.01%
+205,733
New +$876K
ONIT
2609
Onity Group Inc.
ONIT
$367M
$875K ﹤0.01%
87,807
-2,853
-3% -$28.4K
LOAN
2610
Manhattan Bridge Capital
LOAN
$61.3M
$871K ﹤0.01%
186,995
-14,536
-7% -$67.7K
QNRX
2611
Quoin Pharmaceuticals
QNRX
$4.47M
$868K ﹤0.01%
13
+4
+44% +$267K
SGMA
2612
DELISTED
Sigmatron International
SGMA
$868K ﹤0.01%
257,464
-2,400
-0.9% -$8.09K
AMD icon
2613
Advanced Micro Devices
AMD
$257B
$867K ﹤0.01%
16,474
-3,951,752
-100% -$208M
DXLG icon
2614
Destination XL Group
DXLG
$80.3M
$863K ﹤0.01%
1,326,985
+961,174
+263% +$625K
SKYS
2615
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$863K ﹤0.01%
182,057
+71,711
+65% +$340K
NTLA icon
2616
Intellia Therapeutics
NTLA
$1.23B
$862K ﹤0.01%
+41,000
New +$862K
VCLT icon
2617
Vanguard Long-Term Corporate Bond ETF
VCLT
$6.94B
$861K ﹤0.01%
+8,100
New +$861K
RESI
2618
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$860K ﹤0.01%
+98,800
New +$860K
AKRO icon
2619
Akero Therapeutics
AKRO
$3.48B
$859K ﹤0.01%
+34,484
New +$859K
BBGI icon
2620
Beasley Broadcasting Group
BBGI
$9.62M
$858K ﹤0.01%
17,659
-185
-1% -$8.99K
PRVL
2621
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$858K ﹤0.01%
57,600
-21,205
-27% -$316K
SYBX icon
2622
Synlogic
SYBX
$18.6M
$854K ﹤0.01%
28,030
+25,732
+1,120% +$784K
UBP
2623
DELISTED
Urstadt Biddle Properties Inc.
UBP
$853K ﹤0.01%
84,900
-2,200
-3% -$22.1K
CPAH
2624
DELISTED
Counterpath Corp
CPAH
$853K ﹤0.01%
169,155
+147,755
+690% +$745K
CTHR
2625
DELISTED
Charles & Colvard Ltd
CTHR
$851K ﹤0.01%
116,517
+46,440
+66% +$339K